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Abstract
Chlorogenic acid (CGA) has been shown to delay intestinal glucose absorption and inhibit gluconeogenesis. Our aim was to
investigate the role of CGA in the regulation of glucose transport in skeletal muscle isolated from db/db mice and L6
skeletal muscle cells. Oral glucose tolerance test was performed on db/db mice treated with CGA and soleus muscle was
isolated for 2-deoxyglucose transport study. 2DG transport was also examined in L6 myotubes with or without inhibitors
such as wortmannin or compound c. AMPK was knocked down with AMPKa1/2 siRNA to study its effect on CGA-stimulated
glucose transport. GLUT 4 translocation, phosphorylation of AMPK and Akt, AMPK activity, and association of IRS-1 and PI3K
were investigated in the presence of CGA. In db/db mice, a significant decrease in fasting blood sugar was observed
10 minutes after the intraperitoneal administration of 250 mg/kg CGA and the effect persisted for another 30 minutes after
the glucose challenge. Besides, CGA stimulated and enhanced both basal and insulin-mediated 2DG transports in soleus
muscle. In L6 myotubes, CGA caused a dose- and time-dependent increase in glucose transport. Compound c and AMPKa1/
2 siRNA abrogated the CGA-stimulated glucose transport. Consistent with these results, CGA was found to phosphorylate
AMPK and ACC, consistent with the result of increased AMPK activities. CGA did not appear to enhance association of IRS-1
with p85. However, we observed activation of Akt by CGA. These parallel activations in turn increased translocation of GLUT
4 to plasma membrane. At 2 mmol/l, CGA did not cause any significant changes in viability or proliferation of L6 myotubes.
Our data demonstrated for the first time that CGA stimulates glucose transport in skeletal muscle via the activation of AMPK.
It appears that CGA may contribute to the beneficial effects of coffee on Type 2 diabetes mellitus.
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Introduction
Regular consumption of coffee has been associated with a lower
risk of Type 2 diabetes mellitus and it has been replicated across
sexes, geographical locations and obesity levels [1,2,3,4,5,6].
However, Battram et al. (2006) showed that the area under the
curve (AUC) of glucose was significantly lowered during an oral
glucose tolerance test (OGTT) following consumption of decaf-
feinated coffee compared with caffeinated coffee and a placebo
[7]. In addition, with both OGTT [7,8,9,10] and euglycemic-
hyperinsulinemic clamp [9,11,12,13] techniques, caffeine had
been shown to impair insulin sensitivity. These findings suggest
that the beneficial effects of coffee consumption on diabetes may
be caused by compounds other than caffeine.
Besides caffeine, coffee contains numerous compounds like
phenols, diterpenes, trigonelline and minerals such as potassium
and magnesium. Among them, chlorogenic acid [14,15,16,17],
trigonelline [14], quinides [18] and magnesium [19] have been
shown to affect glucose metabolism. Chlorogenic acid (CGA), one
of the phenols in coffee, is the second major component in coffee
after caffeine. It is an ester formed from cinnamic acids and quinic
acid and is also known as 5-O-caffeoylquinic acid (5-CQA)
(IUPAC numbering) or 3-CQA (pre-IUPAC numbering) [20]. It
has been shown to delay glucose absorption in the intestine
through inhibition of glucose-6-phosphate translocase 1 and
reduction of the sodium gradient-driven apical glucose transport
[16]. Besides, CGA and its derivatives decreased hepatic glucose
output through inhibition of the activity of glucose-6-phosphatase
(G-6-Pase) [15,17,21].
Van Dijk et al. (2009) showed that CGA ingestion significantly
reduced early fasting glucose and insulin responses in overweight
men during an OGTT [14]. However, improvement in fasting
glucose and insulin cannot be explained by the delay in intestinal
glucose absorption. At the same year, there was another study
showing that CGA enhanced glucose uptake in skeletal muscle
cells [22]. Hence, we propose that CGA stimulates peripheral
glucose disposal and thus improving fasting glucose profile. In the
present study, we study the effects of CGA on oral glucose
tolerance test performed in db/db mice. We also investigate the
effect of CGA on 2-deoxyglucose (2-DG) transport by skeletal
muscle (in vitro and ex vivo) and its possible mechanism(s) of this
effect. We investigated the effect of inhibitors such as wortmannin
and compound c on 2-DG uptake stimulated by CGA. This is
followed by the study on the expressions of insulin signaling and
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teins involved in the translocation of glucose transporter 4 (GLUT
4). In addition, AMPK was knocked down to investigate its role in
CGA-stimulated 2-DG uptake. We also examined the effect of
CGA on cell viability and proliferation.
Materials and Methods
Materials
CGA, DMEM, Krebs-Ringer bicarbonate buffer (KRBB),
antibiotic/antimycotic, insulin, wortmannin, cytochalasin B,
MTT, AMP, PI/RNase were obtained from Sigma (St. Louis,
MO, USA). Rat L6 skeletal muscle myoblasts were obtained from
ATCC (Manassas, VA, USA). FBS was from Hyclone (Cramling-
ton, UK). DMSO was purchased from MP Biomedicals (Illkirch,
France). Glucose oxidase kits were obtained from Thermo
Scientific (Waltham, MA, USA). Compound c and NP 40 were
obtained from Merck (Darmstadt, Germany). 2-Deoxy-[
3H]D-
glucose and [c-
32P]-ATP were purchased from PerkinElmer
(Waltham, MA, USA). Protease inhibitor cocktail was purchased
from Abcam (Cambridge, UK). AMPK a1/2 and an unrelated
siRNA (control siRNA-A) were purchased from Santa Cruz (Santa
Cruz, CA). Antibodies like anti-IRS-1, anti-PI3-kinase p85a, anti-
GLUT 4, anti-GLUT 1, anti-CAMKKb, anti-phospho-AMPK
a1/2, anti-phospho-Akt1 were obtained from Santa Cruz (Santa
Cruz, CA) too. anti-GAPDH and anti-phospho-ACC were from
Cell Signaling Technology (Danvers, MA, USA) and Milipore
(Billerica, MA, USA) respectively. Oligofectamine and OPTI-
MEM were purchased from Invitrogen (Carlsbad, CA, USA).
Bradford protein estimation kit was from Bio-Rad (Hercules, CA,
USA). G-Sepharose beads and ECL detection kit were obtained
from GE Healthcare (Piscataway, NJ, USA). SAMS peptide was
purchased from Tocris Bioscience (Minneapolis, MN, USA).
Experimental animals
Thirty male db/db mice homozygous for diabetes spontaneous
mutation (Lepr
db) were obtained from The Jackson Laboratory
(Sacramento, CA, USA). Ten C57BL/6 mice were purchased
from Centre for Animal Resources (CARE), National University of
Singapore. They were allowed to acclimatize to conditions in the
Animal Holding Unit (AHU), NUS. They were housed through-
out the experiment on a 12-hour light/dark cycle. Water and feeds
were available to the animals ad libitum.
Ethics statement
The Principles of Laboratory Animal Care (NIH, 1985) were
followed throughout the duration of experiment. The experimental
protocol for animal study was approved by NUS Institutional Animal
Care and Use Committee (IACUC) (Protocol No: 085/07(A3)10).
Oral glucose tolerance test
Twenty db/db mice were randomly assigned into four groups
(n=4) and four C57BL/6 mice were assigned as lean control
group. They were fasted for six hours before the test. Blood
samples were collected from the tail vein for fasting glucose
measurement using glucose oxidase method before treatments
(vehicle, ip 250 mg/kg CGA, oral 250 mg/kg metformin). Ten
minutes after the treatments, blood samples were collected again
followed by oral gavaging of 2 g/kg glucose. Blood samples were
collected 15, 30, 60 and 120 minutes after the glucose challenge.
2DG transport in soleus muscle
Soleus muscle was isolated from db/db mice as described
previously [23]. It was then incubated with treatments (vehicle,
metformin or CGA) in KRBB for 30 minutes at 37uC. Treated
muscle strips were subsequently incubated with 0.5 ml KRBB
containing 1 mCi/ml 2-Deoxy-[
3H]D-glucose for 30 minutes at
37uC. Reaction was terminated by immediately blotting the tissues
and dissolving them in 0.5 N NaOH for an hour followed by
neutralization with equal amount of 0.5 N HCL. After centrifu-
gation, supernatant was collected for quatitation of 2DG taken up
by the tissue using liquid scintillation counter (Beckman Coulter
LS6500 Multi-Purpose Scintillation Counter, Fullerton, CA,
USA). Non-specific uptake was measured in the presence of
10 mmol/l cytochalasin B and subtracted from the total uptake. 2-
DG uptake was expressed as a percentage of the basal uptake of
cells incubated with KRBB buffer only.
Cell culture and differentiation of L6 skeletal muscle
The culture was maintained in DMEM containing 10% FBS
and 1% antibiotic/antimycotic in a humidified atmosphere of 5%
CO2 at 37uC. Differentiation of myoblasts into myotubes was
carried out as described by Klip et al. [24]. L6 myoblast was
seeded in 10% FBS-DMEM until it reached 80–90% confluence;
the FBS content was reduced to 2% for a further 5–7 days to
induce myotube formation. The degree of differentiation was
determined as the percentage of nuclei present in the multinucle-
ated myotubes under a phase-contrast microscope. Before all
experimental manipulations, L6 myotubes were deprived of serum
for 4 hours to render the cells quiescent.
2-Deoxy-[
3H]D-glucose (2-DG) transport in L6 skeletal
muscle
The cells were grown and differentiated in 96-well plates. After
the indicated periods of incubation with different treatments, the
cells were rinsed with KRPH (HEPES-buffered Krebs-Ringer
phosphate) buffer, consisting of 118 mmol/l NaCl, 5 mmol/l KCl,
1.3 mmol/l CaCl2, 1.2 mmol/l MgSO4, 1.2 mmol/l KH2PO4
and 30 mmol/l HEPES (pH 7.4). CGA was prepared in 5%
DMSO and diluted with appropriate amount of DMEM to obtain
different concentrations. 5% DMSO was used for all drug
preparations. For the study with CGA+insulin, myotubes were
treated with 2 mmol/l CGA for 24 hours and stimulated with
100 nmol/l insulin for 30 mins before 2DG uptake measurement.
For the study involving inhibitors, myotubes were pre-incubated
with 100 nmol/l wortmannin or 10 mmol/l compound c for
30 mins before adding CGA. Washed cells were incubated with
10 mmol/l 2-Deoxy-[
3H]D-glucose (1 mCi/ml) in KRPH buffer
for 30 mins at 37uC. The 2-DG uptake was terminated
immediately by aspirating the radioactive incubation solution
and washing three times by ice-cold phosphate-buffered saline
(PBS). The cells were then lysed with 0.5 N NaOH, followed by
0.5 N HCL for neutralization. The quantity of 2-DG taken up by
the cells was measured with liquid scintillation counter. Non-
specific uptake was measured in the presence of 10 mmol/l
cytochalasin B and subtracted from the total uptake. 2-DG uptake
was expressed as a percentage of the basal uptake of cells
incubated with KRPH buffer only.
Myotube subcellular fractionation
The subcellular fractionation of myotubes was done as
previously described [25]. Treated cells were scraped gently from
10 cm dishes and centrifuged at 700 g, 4uC for 10 mins. The
pellet was then resuspended in sucrose buffer, consisting of
250 mmol/l sucrose, 5 mmol/l sodium azide, 2 mmol/l EGTA,
20 mmlol/l HEPES (pH 7.4) and protease inhibitor cocktail, and
homogenized with 20 strokes using a Dounce homogenizer. The
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nuclei and cell debris. The supernatant was collected as total cell
lysate. For plasma membrane isolation, the supernatant was
removed and centrifuged at 31,000 g, 4uC for 60 mins to pellet the
crude plasma membrane (PM). PM fraction was resuspended in
sucrose buffer and stored at 280uC.
siRNA transfection of myotubes
Transfection of siRNA into myotubes was done as described
previously with a minute modification [26]. Cells were seeded and
grown in 6-well plates as described earlier (see section on cell
culture and differentiation). After cells were treated with 2% FBS
for 3 days, siRNAs were transfected with oligofectamine, acoord-
ing to the instructions of the manufacturer. Briefly, the complex
mixture in serum- and antibiotic-free OPTI-MEM was layered
onto the cells and incubated for 4 hours at 37uC. The serum
content was then brought up to 2% by adding half volume of
antibiotic-free DMEM supplemented with 6% FBS and incubated
for an additional 20 hours. Another volume of 2%-FBS DMEM
with antibiotic was then added and incubated for further 24 hours
to allow the siRNA to remain on the cells for a total of 48 hours.
Immunoprecipitation and detection of association
between IRS-1 and p85 subunit of PI3K
Treated cells were scraped gently from 6-well plate and pelleted
with ice-cold PBS at 3,000 rpm, 4uC for 5 minutes. Cell pellet was
then lysed in lysis buffer (50 mmol/l Tris [pH 8], 170 mmol/l
NaCl, 1 mmol/l DTT, 0.5% NP40 and protease inhibitor cocktail
for 30 minutes at 4uC. Cell lysate was then centrifuged at
13,000 rpm for 10 minutes to remove cell debris. 2 ml of the cell
lysate was used for Bradford protein estimation. 1 mg of total
cellular protein was immunoprecipitated with 1 mg of anti-IRS-1
antibody coupled to 40 ml of 100 mg/ml protein G-Sepharose
beads. Immunoprecipitated proteins, together with the beads,
were separated with SDS-PAGE and blotted as mentioned in the
western blot analysis below. Blotted proteins were probed with
anti-PI3-kinase p85a antibody.
Western blot analysis
Treated cells were scraped from 6-well plates and pelleted with
ice-cold PBS at 3,000 rpm, 4uC for 5 minutes. Cell pellets were
then lysed in lysis buffer containing 250 mmol/l sucrose,
150 mmol/l NaCl, 50 mmol/l HEPES (pH 7.4) 10 mmol/l
sodium fluoride, 1 mmol/l sodium pyrophosphate, 1 mmol/l
sodium orthovanadate, 1 mmol/l DTT, 0.5 mmol/l EDTA, 1%
Triton-X 100 and proteases inhibitors cocktail. Cell lysates were
separated via SDS-PAGE and the separated proteins were blotted
onto nitrocellulose membrane. Membranes were probed with anti-
GAPDH, anti-GLUT 4, anti-GLUT 1, anti-phospho-AMPK a1/
2, anti-phospho-Akt1 and anti-phospho-ACC. They were then
developed using the ECL detection kit.
Cellular viability and proliferation analysis
Myotube viability and proliferation were assayed with MTT
and propidium iodode (PI) staining. For the MTT assay, cells were
treated with different concentrations of CGA for 24 hours and
then incubated with 5 mg/ml MTT for a fruther 4 hours at 37uC.
Medium was then removed and 100 ml of DMSO was added to
dissolve the formazan crystal formed. Absorbance was measured at
a wavelength of 500 nm with a microplate reader (Tecan Infinite
m200, Mannedorf, Switzerland). Similarly, for the PI staining,
cells were trypsinized and washed with PBS after incubation with
different concentrations of CGA for 24 hours. The cells were then
fixed in 70% ethanol at 4uC for at least 2 hours. After fixation, the
cells were stained with PI/RNase in PBS supplemented with 1%
FBS at room temperature for 20 mins before proceeding to flow
cytometry analysis, using cyAn ADP Flow Cytometer (Beckman
Coulter, Brea, CA).
AMPK activity assay
Myotubes were treated with CGA of different concentrations for
indicated periods of time. Treated cells were scraped and pelleted
with ice-cold PBS at 3,000 rpm, 4uC for 5 minutes. Cell pellets
were then lysed in lysis buffer containing 250 mmol/l sucrose,
150 mmol/l NaCl, 50 mmol/l HEPES (pH 7.4) 10 mmol/l
sodium fluoride, 1 mmol/l sodium pyrophosphate, 1 mmol/l
sodium orthovanadate, 1 mmol/l DTT, 0.5 mmol/l EDTA, 1%
Triton-X 100 and proteases inhibitors cocktail. 2 ml of the cell
lysate was used for Bradford protein estimation. 1 mg of total
cellular protein was immunoprecipitated with 1 mg of anti-AMPK
a1/2 antibody coupled to 40 ml of 100 mg/ml protein G-
Sepharose beads. Kinase reaction was carried out on washed
immunoprecipitate in 40 mmol/l HEPES (pH 7.0), 0.2 mmol/l
AMP, 80 mmol/l NaCl, 0.8 mmol/l DTT, 5 mmol/l MgCl2,
0.2 mmol/l ATP (2 mCi [c-ATP]) and 0.1 mmol/l SAMS peptide
for 20 minutes at 37uC. Reaction mixture was then spotted on P81
Whatman filter paper and washed extensively using phosphoric
acid and acetone. Radioactivity on the filter paper was measured
using liquid scintillation. Kinase activity was expressed as
incorporated ATP/mg protein/minute.
Statistical analysis
Experiments were repeated three times, each time in triplicate.
Valuesareexpressedasmean6SE.One-wayANOVA followedby
Tukey’s t test was used to determine significant differences between
groups. P values,0.05 were interpreted as statistically significant.
Results
CGA decreased fasting blood glucose in db/db mice
In an oral glucose tolerance test, 250 mg/kg CGA was found to
significantly lower fasting blood glucose for 3169% compared to
diabetic control 10 minutes after the intraperitoneal injection
(Fig. 1A). This glucose-lowering effect persisted up to 30 minutes
and gradually diminished when approaching 60 minutes after the
glucose loading. Optimum effect with a significant decrease of
3869% was observed at 15 minutes after the glucose loading.
CGA stimulated glucose transport in soleus muscle
isolated from db/db mice
Soleus muscle isolated from db/db mice showed a significant
increase in glucose transport after treated with CGA (Fig. 1B).
2 mmol/l of CGA increased the glucose transport of myotubes by
48613% and the stimulation continued to increase and achieve
stability at higher concentrations. No significant difference in
glucose transport was observed between lean mice and diabetic
mice. However, a significant decrease of 5463% in insulin-
stimulated glucose transport was shown in diabetic mice compared
to lean mice. CGA treatment further enhanced the insulin-
mediated glucose transport for up to 145613% at the concentra-
tions of 4,8 and 10 mmol/l compared to diabetic control.
Dose- and time-dependent stimulation of glucose
transport by CGA in L6 skeletal muscle cells
Treatment of myotubes with increasing concentrations of CGA
for 24 hours led to a significant dose-dependent increase in glucose
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tolerance test was performed on db/db mice (n=4) treated with different treatments. 2 g/kg glucose was loaded at 0 minute. Blood samples were
collected at 210, 0, 15, 30 60 and 120 minutes for glucose measurement. Results are the mean 6 SD of four mice. B: Soleus muscle was isolated from
db/db mice and treated with CGA or/and 100 nmol/l insulin or 2 mmol/l metformin for 30 minutes. 2-deoxyglucose uptake was measure over a 30-
minute period, using liquid scintillation counter. Results are the mean 6 SE of three independent experiments. *P,0.05, **P,0.01 compared with
controls. DC=Diabetic Control.
doi:10.1371/journal.pone.0032718.g001
Figure 2. Dose- and time-dependent stimulation of glucose transport in L6 myotubes by CGA. A: L6 myotubes were incubated with
incremental concentrations of CGA for 24 hours. B: L6 myotubes were incubated with 2 mmol/l CGA at different incubation periods up to 24 hours.
2-deoxyglucose uptake was measure over a 30-minute period, using liquid scintillation counter. Readings are expressed as percentage increase over
basal uptake of cells incubated with vehicle. Results are the mean 6 SE of three independent experiments. *P,0.05, **P,0.01 compared with
vehicle-treated control.
doi:10.1371/journal.pone.0032718.g002
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highest increase was observed at 2 mmol/l (6366%) and the
stimulation was maintained up to the highest concentration tested,
which was 10 mmol/l (Fig. 2A). Besides, a time-dependent
stimulation of glucose transport was also observed when myotubes
were incubated with 2 mmol/l CGA at different incubation
periods. Significant increase was first observed after 1-hour
incubation (1461%), and continued to increase to 6065% after
24 hours of incubation (Fig. 2B). In all subsequent experiments,
the effects of CGA were determined at a concentration of
2 mmol/l and incubation period of 24 hours.
Compound c diminished glucose transport stimulated by
CGA
To explain the mechanism underlying the glucose transport
stimulated by CGA, we examined the effect of several molecules
which are capable of mediating the stimulation of glucose
transport. Wortmannin is a well-known selective inhibitor for
phosphatidylinositol 3-kinase (PI3K), a key regulator in insulin
signaling [27]. Pretreatment of myotubes with 100 nmol/l
wortmannin for 30 minutes abolished the stimulatory effect of
insulin on glucose transport (Fig. 3A). However, no effect was
observed with the wortmannin pretreatment on CGA-stimulated
glucose transport. CGA further increased insulin-stimulated
glucose transport its glucose transport up to 10062%, suggesting
that CGA may not work on the insulin-dependent pathway.
Moreover, pretreatment of CGA and insulin-stimulated transport
with wortmannin only partially inhibited the stimulation but not to
the extent of that obtained in insulin-only-stimulated transport.
Hence, to investigate whether CGA acts through the insulin-
independent pathway, we examined the effect of compound c, a
selective inhibitor of AMP-activated protein kinase (AMPK)
[28,29], on the CGA-stimulated glucose transport. Pretreatment
with 10 mmol/l compound c for 30 minutes significantly abated
the glucose transport stimulated by both metformin and CGA
(Fig. 3B).
AMPK is necessary for the glucose transport stimulation
by CGA
Besides using inhibitor compound c, AMPKa content was
reduced with RNA silencing. AMPKa 1/2 siRNA nucleotides
reduced the total expression of AMPKa 1/2 by 7467%
compared with transfection with equal concentration of unrelated
control siRNA sequence (Fig 4B). Transfection with AMPKa 1/2
or unrelated siRNAs alone did not affect glucose transport.
However, reduction in total expression of AMPKa 1/2
significantly reduced glucose transport stimulated by CGA by
5865% (Fig. 4A). Unrelated control siRNA did not significantly
affect CGA-stimulated glucose transport, though a slight increase
was detected. Taken together, the data suggested that AMPK
may have a major contribution to CGA-induced stimulation of
glucose transport.
Figure 3. Effects of compound c on CGA-stimulated glucose transport. L6 myotubes were incubated with 2 mmol/l CGA for 24 hours.
A: Myotubes were preincubated with 100 nmol/l wormannin for 30 minutes before incubated with CGA or insulin. Myotubes were then incubated
with 100 nmol/l insulin 30 minutes before 2-deoyglucose uptake measurement. B: Myotubes were preincubated with 10 mmol/l compound c for
30 minutes before incubated with CGA or metfformin. Myotubes were then incubated with 2 mmol/l metformin 2 hours before 2-deoyglucose
uptake measurement. 2-deoxyglucose uptake was measured over a 30-minute period using liquid scintillation counter. Readings are expressed as
percentage increase over basal uptake of cells incubated with vehicle. Results are the mean 6 SE of three independent experiments. *P,0.05,
**P,0.01 compared with controls.
doi:10.1371/journal.pone.0032718.g003
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through AMPK activation
Glucose transport is mediated by the members of GLUT protein
family, which consists of 12 transmembrane transporters [30]. We
therefore investigated whether the glucose transport in response to
CGA was accompanied by an increase in translocation of the two
major transporters responsible for tissue glucose disposal, GLUT 1
and/or GLUT 4, to the plasma membrane of myotubes. Treatment of
myotubes with CGA for different time periods augmented GLUT 4
content on plasma membrane of myotubes, with the significant
increase first observed at 1-hour incubation, increasing in a time-
dependent manner for up to 24 hours (Fig. 5A). Metformin
demonstrated a similar increase in GLUT 4 on plasma membrane
of myotubes. However, neither metformin nor CGA caused significant
changes in total GLUT 4 expression or plasma membrane-GLUT 1.
AMPK activation has been associated with increased GLUT 4
translocation to plasma membrane and enhanced glucose transport
[31,32]. We have shown that AMPK is vital for CGA to enhance
glucose transport. Thus, to further show that CGA activates AMPK,
we evaluated the effect of CGA on AMPK phosphorylation and
likewise its downstream substrate, ACC. Like metformin, CGA
increased AMPK phosphorylation on T172 and also ACC phosphor-
ylation on S79 in a time- (Figure 5B) and dose-dependent (Figure 5C)
manners. In addition, AMPK activity was increased time- and dose-
d e p e n d e n t l ya l s ob yC G Aa n dt h e r e f o re explaining its phosphorylation
stimulated by CGA (Figure 6A). Several upstream signaling were
known to phosphorylate AMPK such as cellular stress that causes a fall
in ATP: AMP ratio [33], tumor suppressor kinase LKB-1 [34] and
CaMKK [35]. We here for the first time showed that activation of
AMPK by CGA was mediated by CaMKK (Figure 5B & 5C).
CGA did not induce association of p85 subunit of PI3K to
IRS-1
Activation of PI3K requires association of its p85 subunit to
IRS-1 as shown by insulin in Fig. 6C. However, CGA did not
produce any significant effect on the association of p85 to IRS-1
immunoprecipitates of myotubes compared to the association
observed in vehicle-treated myotubes. This again suggests that
the stimulatory effect of CGA on glucose transport may not be
attributable to PI3K activation. To further examine whether
CGA activates the PI3K-Akt pathway, we investigated the effect
of CGA on Akt phorphorylation. Surprisingly, we observed that
Akt was phosphorylated at Thr 308 by insulin as well as CGA
(Fig. 6D).
Effect of CGA on cell viability and cell proliferation
To discard the possibility that increases in glucose transport in
response to CGA might be due to the changes in myotube
numbers, we assessed the effect of increasing doses of CGA on cell
viability and cell proliferation. No significant changes were
observed up to a concentration of 4 mmol/l (Fig. 7A). However,
significant increases in cell death were observed at 6 mmol/l
(17.465%), 8 mmol/l (19.964%) and 10 mmol/l (17.664%)
compared to vehicle-treated myotubes. On the other hand,
myotubes treated with different concentrations of CGA did not
produce any significant changes in all three cell-cycle phases, G0/
G1, S and G2/M, compared to the vehicle-treated myotubes
(Fig. 7B). Taken together, at the concentration of 2 mmol/l, CGA
did not cause significant cell death or cell-cycle arrest, thus
eliminating the possibility that cell numbers may affect the study of
glucose transport.
Figure 4. Effects of gene silencing of AMPK on CGA-stimulated glucose transport in L6 myotubes. L6 myotubes were transfected with
vehicle, unrelated siRNA or AMPKa1/2 siRNA as described in Research Design and Methods. A: Expression of AMPKa1/2 after transfection with or
without unrelated siRNA or AMPKa1/2 siRNA. B: Transfected or non-transfected myotubes were incubated with 2 mmol/l CGA for 24 hours. 2-
deoxyglucose uptake was measure over a 30-minute period using liquid scintillation method. Readings were expressed as percentage increase over
basal uptake that was obtained from non-transfeted cells incubated with vehicle. Results are the mean 6 SE of three independent experiments.
**P,0.01 compared with non-transfected-control treated with CGA.
doi:10.1371/journal.pone.0032718.g004
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The estimated prevalence of diabetes among adults in 2001 was
171 million people and was expected to increase to 366 million
people by 2030 [36]. Majority of the diabetic cases, especially of
Type 2 diabetes, are associated with diet and lifestyle manage-
ments. Coffee holds second position in consumption among all
non-alcoholic beverages after water, and people from all over the
world consume approximately 500 million cups of coffee every
year [37]. An inverse relation between coffee and type 2 diabetes
Figure 5. Dose- and time- dependent phosphorylation of AMPK. A: Myotubes were treated with 2 mmol/l CGA for various incubation periods
up to 24 hours. Plasma membranes were isolated and detected for GLUT 4 and GLUT 1 through immunoblotting. B: Myotubes were treated with
2 mmol/l CGA for various incubation periods up to 24 hours. C: Myotubes were treated with incremental doses of CGA for 24 hours. Whole cell lysate
was used for the detection of p-AMPK, AMPK, p-ACC, ACC and CaMKKb. Illustrated are the representative images of three independent experiments.
Results are the mean 6 SE of three independent experiments. *P,0.05, **P,0.01 compared with controls.
doi:10.1371/journal.pone.0032718.g005
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caffeine, magnesium, and blood pressure [38]. Previous studies of
CGA, the second abundant component in coffee after caffeine,
showed its ability to delay intestinal glucose absorption and inhibit
hepatic glucose output [15,16,17,21]. There is no study to
implicate CGA to peripheral glucose disposal until Prabhakar
and Doble showed for the first time that CGA stimulated glucose
transport in myotubes via increased expression of GLUT 4 and
PPAR-c transcript [22]. However, merely increase in GLUT 4
gene expression cannot explain the increase in glucose transport
and the study lacks clarification on the mechanisms involved to
enhance glucose transport in skeletal muscle.
In the present study, we showed for the first time the effect of
CGA on fasting blood glucose in a diabetic animal model. db/db
mice with homozygous spontaneous mutation of leptin receptor is
a diabetic model showing Type 2 diabetic characteristics such as
obese, uncontrolled rise in blood glucose and insulin. Intraperi-
toneal injection of CGA lowered the fasting blood glucose in db/
db mice and this is consistent with the findings from Van Dijk et al.
(2009) in overweight patients [14]. In addition, we found out that
this effect continued to last for another 30 minutes after the
diabetic animals were challenged with 2 g/kg of glucose. We
believed that although its duration of action is relatively short
compared to metformin, long-term consumption of CGA may be
beneficial as seen in coffee consumption. Further long-term study
is required to support this hypothesis. Decrease in fasting blood
glucose can be due to increased glucose disposal in peripheral
tissues such as skeletal muscle. Hence, soleus muscle was isolated
from db/db mice and treated with CGA followed by 2DG
transport assay. CGA was shown to stimulate and enhance both
basal and insulin-mediated glucose transports and thus augment-
ing glucose utilization in the muscle. Addictive effect of CGA in
insulin-mediated glucose transport suggests that CGA may act
through a significant pathway which is different from insulin
signaling.
To further support the data we found using the db/db mice, we
investigated the effect of CGA on glucose transport in L6
myotubes and the possible mechanisms to execute its function in
glucose transport. The results of our study showed that CGA
stimulated glucose transport in L6 myotubes in a dose- and time-
dependent manner. Optimum increase (,1.5 fold) was observed at
the dose of 2 mmol/l after 24-hour incubation period, compared
Figure 6. Increased AMPK activity and Akt phosphorylation in the absence of PI3K activation by CGA. A: Myotubes were treated with
2 mmol/l CGA for various incubation periods up to 24 hours. B: Myotubes were treated with 2 mmol/l CGA for various incubation periods up to
24 hours. Whole cell lysate was immunoprecipitated with anti-AMPK a1/2. Immunoprecipitate was assayed against SAMS peptide in the presence of
[c-
32P]ATP. Kinase activity was expressed as incorporated ATP/mg protein/minute. C: Myotubes were treated with vehicle, 100 nmol/l insulin or
2 mmol/l CGA. Whole cell lysate was immunoprecipitated with IRS-1 and immunoblotted for IRS-1 and p85 subunit of PI3K. D: Myotubes were treated
with vehicle, 100 nmol/l insulin or 2 mmol/l CGA. Whole cell lysate was detected for p-Akt through immunoblotting. Results are the mean 6 SE of
three independent experiments. *P,0.05, **P,0.01 compared with controls.
doi:10.1371/journal.pone.0032718.g006
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assay, Prakhabar and Doble (2009) demonstrated that CGA
caused significant increase of glucose transport at micromolar
concentration. However, we found that micromolar amounts of
CGA only mildly stimulated glucose transport (data not shown).
To examine the mechanism by which CGA exerts its effect on
glucose transport, we used several selective glucose transport
inhibitors, such as wortmannin and compound c, which inhibit
PI3K and AMPK respectively. We found that wortmannin did not
affect CGA-stimulated glucose transport whereas compound c
significantly decreased glucose uptake stimulated by CGA. In
addition, AMPK knockdown also abolished the stimulatory effect
caused by CGA on glucose transport of myotubes. Taken together,
these results suggest that the effect of CGA on glucose transport
may possibly be mediated by AMPK.
AMPK is a master sensor and regulator of cellular energy
balance [39]. It is activated by various pharmacological,
pathological and metabolic stressors such as metformin, thiazoli-
dinediones, hypoxia and exercise. Activation of AMPK leads to
translocation of GLUT 4 from intracellular membranes to plasma
membranes, thus increasing glucose transport [40]. Consistent
with this, our results showed a time- and dose-dependent increase
in phosphorylation of AMPK and likewise its activity, leading to
an increase in the number of GLUT 4 on the plasma membrane of
myotubes. However, no changes were observed on the transloca-
tion of GLUT 1, suggesting that CGA may only affect insulin-
sensitive tissues such as skeletal muscles, liver and adipocytes.
Calmodulin-dependent protein kinase kinase-b (CaMKKb) has
been reported as an alternative upstream kinase for AMPK besides
cellular stress and LKB-1 [35]. We examined whether CGA
causes any changes in ATP: AMP ratio but no significant changes
were observed (data not shown). We found out later that CGA
increased expression of CaMKKb and this may be the upstream
target of CGA that activates AMPK. In accord with the earlier
report [22] that CGA did not show any significant effect on the
expression of PI3K, we further demonstrated that CGA did not
activate PI3K as no significant association was observed between
p85 subunit of PI3K and IRS-1, suggesting a negative role of CGA
on phosphorylation of IRS. However, to our surprise, we observed
phosphorylation of Akt in the absence of PI3K activation. In rat
heart, phosphorylation of Akt has been shown to phosphorylate
AMPKa1 subunit at Ser 485/491 a hence interfering with the
Figure 7. Effect of CGA on cell viability and cell proliferation of L6 myotubes. Myotubes were incubated with incremental concentrations
of CGA for 24 hours. A: Viability of myotubes was measured using MTT staining. Readings are expressed as a percentage of non-viable cells compared
to vehicle-treated myotubes. B: Numbers of cells in cell-cycle phases were examined using propidium iodide staining and FACS analysis. Readings are
expressed as percentage of cells stained by propidium iodide at different phases. Results are the mean 6 SE of three independent experiments.
*P,0.05 compared with vehicle-treated control.
doi:10.1371/journal.pone.0032718.g007
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This indicates that Akt negatively influenced AMPK activation
and activity. Other groups of researchers have reported that
several stimuli such as adiponectin [42] and VEGF, [43] elicited
parallel activation of both AMPK and Akt. Likewise, they
proposed the upstream nature of AMPK, by which Akt is
activated by the phosphorylation of AMPK at Thr 172. This is
highly notable as both insulin-dependent and AMPK-dependent
pathways converge to activate Akt substrate of 160 kDa (AS160)
and Akt may be the point of convergence instead of AS160. Our
results seem to favour the latter but subsequent studies to
determine the activities of AMPK and Akt are required to support
the occurrence of this phenomenon.
Several studies have reported that AMPK activation by the
well-known AMPK activator, AICAR, led to cell cycle arrest
which involved accumulation of tumor suppressor protein p53
[44,45]. However, we did not detect any significant changes on
cell viability and cell cycle of L6 myotubes even after 24 hours of
incubation in the presence of 2 mmol/l CGA. This might be due
to the parallel activation of pro-survival Akt, as Akt regulates
apoptosis through direct targets such as Bad, caspase 9, the
Forkhead family of transcription factors and the NF-kB regulator,
IKK [46]. More importantly, the data eliminates the possibility
that the increase in glucose transport might be due to the effect of
CGA on cell proliferation.
In summary, we have demonstrated that CGA decreases fasting
blood glucose in db/db mice using a glucose tolerance test. Also,
CGA stimulated glucose transport in skeletal muscle through the
translocation of GLUT 4, mediated by the activation of AMPK.
At 2 mmol/l, CGA did not cause any deleterious effect on cell
viability and cell proliferation. As a second major component in
coffee, these data, together with those shown by other studies
[15,16,17,20,21,22], strongly suggest that CGA may contribute, at
least in part, to the beneficial effect of coffee in blood glucose level
of patient with Type 2 diabetes. However, further experiments are
needed to support our hypothesis that CGA increases peripheral
glucose disposal in skeletal muscle and therefore lowering fasting
blood glucose.
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